The five year grant will concentrate on the CorOpTrial: A Novel Platform for Cardiovascular Clinical Trials-in-a-Dish Based on Optogenetic-Controlled, Patient-Heterogeneity-Integrated Human Organoids
Focus on Heart Failure with Preserved Ejection Fraction as a proof-of-concept
Comments